Study Overview: This study checks the long-term safety of a drug called pegvaliase for treating PKU, a condition where people can't break down the amino acid phenylalanine (Phe) properly. The study lasts 10 years and looks at any allergic reactions or other safety concerns.
What to Expect: If you join, your doctor will share your medical history and any reactions you have to the drug. There are no extra visits or tests required. Your doctor will see you as usual, checking on your health as part of regular care.
- The study lasts for 10 years.
- No extra doctor visits or tests are needed.
- No new treatments are being tested during this study.